Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin

BSE2114.1033.75 (+1.62 %)

PREV CLOSE ( ) 2080.35

OPEN PRICE ( ) 2085.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12360

TODAY'S LOW / HIGH ( )2081.80 2117.10

52 WK LOW / HIGH ( )1774 2403.45

NSE2113.9032.1 (+1.54 %)

PREV CLOSE( ) 2081.80

OPEN PRICE ( ) 2083.00

BID PRICE (QTY) 2113.90 (5)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 574240

TODAY'S LOW / HIGH( ) 2080.00 2117.20

52 WK LOW / HIGH ( )1795.2 2402.9

Chairman	Manju D Gupta
Managing Director	Nilesh Gupta
Company Secretary	Amit Kumar Gupta
Executive Director	Ramesh Swaminathan
Non Executive Independent Director	K B S Anand Punita Kumar Sinha Mark D McDade Jeffrey Kindler Alfonso Zulueta Punita Lal

Incorporation Year : 01-03 1983

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East) Mumbai,
Maharashtra-400055 .

Phone : 022 66402323

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE